| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $434.4M | +624.1% |
| R&D Expense | $138.1M | +15.0% |
| SG&A Expense | $43.5M | +29.8% |
| Operating Income | $252.8M | +370.0% |
| Pre-tax Income | $279.4M | +453.9% |
| Income Tax | $4.2M | — |
| Net Income | $275.2M | +448.5% |
| EPS (Basic) | $4.47 | +421.6% |
| EPS (Diluted) | $4.23 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $97.2M | -47.9% |
| Short-term Investments | $321.7M | +107.7% |
| Current Assets | $591.6M | +66.4% |
| Total Assets | $744.7M | +108.1% |
| Current Liabilities | $47.4M | +122.8% |
| Total Liabilities | $69.4M | +226.4% |
| Stockholders' Equity | $675.3M | +100.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $184.2M | +362.2% |
| Capital Expenditures | $1.4M | +122.5% |
| Investing Cash Flow | -$299.5M | -662.9% |
| Financing Cash Flow | $25.9M | -84.8% |
| Free Cash Flow | $182.8M | +358.0% |
| +404.3% |